Q11 Development and Manufacture of Drug Substances
Detailed guidance document from FDA and regulatory agencies.
Document Details
Guidance Document
November 20, 2012
May 15, 2020
8d1aacb1-7da4-42f7-9a3a-18b2fc871411
Related Documents
S6 (R1) Addendum: Preclinical Safety Evaluation of Biotechnology - Derived Pharmaceuticals
Guidance DocumentDecember 16, 2009Center for Drug Evaluation and Research
S2(R1) Genotoxicity Testing and Data Interpretation for Pharmaceuticals Intended for Human Use
Guidance DocumentJune 7, 2012Center for Drug Evaluation and Research
S6(R1) Addendum: Preclinical Safety Evaluation of Biotechnology: Guidance for Industry
Guidance DocumentDecember 17, 2009Center for Drug Evaluation and Research
Quick Actions
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.
Try KeyPedia Today
Explore our real use cases and discover our features in depth.
Stay ahead of FDA enforcement
New KeyPedia insights, webinars, and regulatory analysis — straight to your inbox. Unsubscribe anytime.